TIR-Domain-Containing Adapter-Inducing Interferon- β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine

Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regu...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical & cellular immunology Vol. 7; no. 5
Main Authors Kanagavelu, Saravana, Flores, Claudia, Hagiwara, Shinichiro, Ruiz, Jose, Hyun, Jinhee, Cho, Ei E, Sun, Frank, Romero, Laura, Shih, David Q, Fukata, Masayuki
Format Journal Article
LanguageEnglish
Published United States 01.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regulated by innate immunity, we addressed whether TRIF signaling regulates Tfh cell differentiation and its ability to trigger humoral immune responses in the intestine. CD4 CXCR5 T cells, B cells, and plasma cells in the Peyer's patches (PPs) of WT and TRIF-deficient (Trif ) mice were analyzed by flow cytometry at the baseline, 9 days post primary infection, and 7 days post-secondary infection with . -specific CD4 CXCR5 T cells were generated by co-culturing peritoneal macrophages with splenic naïve T cells in the presence of lysate. WT and Trif mice received CD4 CXCR5 T cells isolated either from -primed WT mice or generated . These mice were infected with and followed up to 4 weeks. -specific IgA and IgG were measured in stool and serum samples, respectively. At baseline, CD4 CXCR5 T cell proportion was higher but the proportion of B cells and plasma cells was lower in the PPs of Trif mice compared to WT mice. After infection, the proportion of plasma cells also became higher in the PPs of Trif mice compared to WT mice. Corresponding increase of -specific stool IgA but not serum IgG was found in Trif mice compared to WT mice. Both isolated and generated CD4 CXCR5 T cells induced protective immunity against infection. Our results reveal a novel role of TRIF in the regulation of humoral immunity in the intestine that can be utilized as a basis for a unique vaccine strategy.
AbstractList Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regulated by innate immunity, we addressed whether TRIF signaling regulates Tfh cell differentiation and its ability to trigger humoral immune responses in the intestine. CD4 CXCR5 T cells, B cells, and plasma cells in the Peyer's patches (PPs) of WT and TRIF-deficient (Trif ) mice were analyzed by flow cytometry at the baseline, 9 days post primary infection, and 7 days post-secondary infection with . -specific CD4 CXCR5 T cells were generated by co-culturing peritoneal macrophages with splenic naïve T cells in the presence of lysate. WT and Trif mice received CD4 CXCR5 T cells isolated either from -primed WT mice or generated . These mice were infected with and followed up to 4 weeks. -specific IgA and IgG were measured in stool and serum samples, respectively. At baseline, CD4 CXCR5 T cell proportion was higher but the proportion of B cells and plasma cells was lower in the PPs of Trif mice compared to WT mice. After infection, the proportion of plasma cells also became higher in the PPs of Trif mice compared to WT mice. Corresponding increase of -specific stool IgA but not serum IgG was found in Trif mice compared to WT mice. Both isolated and generated CD4 CXCR5 T cells induced protective immunity against infection. Our results reveal a novel role of TRIF in the regulation of humoral immunity in the intestine that can be utilized as a basis for a unique vaccine strategy.
OBJECTIVEEstablishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regulated by innate immunity, we addressed whether TRIF signaling regulates Tfh cell differentiation and its ability to trigger humoral immune responses in the intestine. METHODCD4+CXCR5+ T cells, B cells, and plasma cells in the Peyer's patches (PPs) of WT and TRIF-deficient (TrifLPS2) mice were analyzed by flow cytometry at the baseline, 9 days post primary infection, and 7 days post-secondary infection with Y. enterocolitica. Y. enterocolitica-specific CD4+CXCR5+ T cells were generated in vitro by co-culturing peritoneal macrophages with splenic naïve T cells in the presence of Y. enterocolitica lysate. WT and TrifLPS2 mice received CD4+CXCR5+ T cells isolated either from Y. enterocolitica-primed WT mice or generated in vitro. These mice were infected with Y. enterocolitica and followed up to 4 weeks. Y. enterocolitica-specific IgA and IgG were measured in stool and serum samples, respectively. RESULTSAt baseline, CD4+CXCR5+ T cell proportion was higher but the proportion of B cells and plasma cells was lower in the PPs of TrifLPS2 mice compared to WT mice. After infection, the proportion of plasma cells also became higher in the PPs of TrifLPS2 mice compared to WT mice. Corresponding increase of Y. enterocolitica-specific stool IgA but not serum IgG was found in TrifLPS2 mice compared to WT mice. Both in vivo isolated and in vitro generated CD4+CXCR5+ T cells induced protective immunity against Y. enterocolitica infection. CONCLUSIONOur results reveal a novel role of TRIF in the regulation of humoral immunity in the intestine that can be utilized as a basis for a unique vaccine strategy.
Author Flores, Claudia
Ruiz, Jose
Hyun, Jinhee
Kanagavelu, Saravana
Sun, Frank
Cho, Ei E
Romero, Laura
Fukata, Masayuki
Hagiwara, Shinichiro
Shih, David Q
AuthorAffiliation 4 Department of Microbiology & Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA
3 Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA
2 Division of Infectious Diseases and Immunology, Department of Biomedical Science, Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA
1 Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
AuthorAffiliation_xml – name: 1 Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– name: 3 Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA
– name: 4 Department of Microbiology & Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA
– name: 2 Division of Infectious Diseases and Immunology, Department of Biomedical Science, Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA
Author_xml – sequence: 1
  givenname: Saravana
  surname: Kanagavelu
  fullname: Kanagavelu, Saravana
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Division of Infectious Diseases and Immunology, Department of Biomedical Science, Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 2
  givenname: Claudia
  surname: Flores
  fullname: Flores, Claudia
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 3
  givenname: Shinichiro
  surname: Hagiwara
  fullname: Hagiwara, Shinichiro
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 4
  givenname: Jose
  surname: Ruiz
  fullname: Ruiz, Jose
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 5
  givenname: Jinhee
  surname: Hyun
  fullname: Hyun, Jinhee
  organization: Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA
– sequence: 6
  givenname: Ei E
  surname: Cho
  fullname: Cho, Ei E
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 7
  givenname: Frank
  surname: Sun
  fullname: Sun, Frank
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 8
  givenname: Laura
  surname: Romero
  fullname: Romero, Laura
  organization: Department of Microbiology & Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA
– sequence: 9
  givenname: David Q
  surname: Shih
  fullname: Shih, David Q
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
– sequence: 10
  givenname: Masayuki
  surname: Fukata
  fullname: Fukata, Masayuki
  organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27853628$$D View this record in MEDLINE/PubMed
BookMark eNpVUNtKw0AQXaRia-0H-CL7WJHU3exusnkRSrQaKAghgm9hk0zaSLKJuQj-lh_iN7lqLfXpzJk5c-Zyika61oDQOSULTl372qZCWJ70vAUlhHAhj9BknxsdxGM067oXoyHMUCZO0Nh2pWCOLSeoioLQuq0rVWjLr3VvsNAbvMxU00NrBTob0u9EoA3Noa21hT8_8DwKg9UlDmEzlKqHDvvPfiiucIS3UDbQYh_KssOFxv0Wfpq7vtBwho5zVXYw2-EUPa3uIv_BWj_eB_5ybTWUUsfi0nZs4BnPqKTEy1NI3STnjDiEQwqeINIolJdQnjCSCoemjDHCpQtMgaPYFN38-jZDUkGWgu5bVcZNW1SqfY9rVcT_K7rYxpv6LRaUSCEdYzDfGbT162CWj6uiS81NSkM9dDGVnFImhUuM9OJw1n7I34_ZFyEegGM
ContentType Journal Article
DBID NPM
7X8
5PM
DOI 10.4172/2155-9899.1000458
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2155-9899
ExternalDocumentID 27853628
Genre Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI095255
– fundername: NIAID NIH HHS
  grantid: R56 AI095255
GroupedDBID 8TZ
ALMA_UNASSIGNED_HOLDINGS
KQ8
NPM
OK1
7X8
5PM
ID FETCH-LOGICAL-p1116-48262e4d4d18109fcec7bf430604ece9508826a9b14b30c561c3330487e3ae6a3
ISSN 2155-9899
IngestDate Fri Sep 01 02:38:27 EDT 2023
Fri Jun 28 17:01:38 EDT 2024
Fri Sep 17 20:16:47 EDT 2021
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords Bacterial infection
Intestine
Mucosal vaccine
Plasma cells
Innate immunity
B cells
Enterocolitis
T follicular helper cells
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p1116-48262e4d4d18109fcec7bf430604ece9508826a9b14b30c561c3330487e3ae6a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 27853628
PQID 1841138570
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5108586
proquest_miscellaneous_1841138570
pubmed_primary_27853628
PublicationCentury 2000
PublicationDate 2016-Oct
PublicationDateYYYYMMDD 2016-10-01
PublicationDate_xml – month: 10
  year: 2016
  text: 2016-Oct
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical & cellular immunology
PublicationTitleAlternate J Clin Cell Immunol
PublicationYear 2016
References 27096318 - Immunity. 2016 Apr 19;44(4):875-88
25631080 - J Virol. 2015 Apr;89(8):4158-69
25620548 - Cell Host Microbe. 2015 Feb 11;17(2):153-63
15606348 - Expert Rev Vaccines. 2004 Dec;3(6):643-54
27120165 - Nature. 2016 May 5;533(7601):42-3
25699040 - Front Immunol. 2015 Feb 02;6:16
19741596 - Mucosal Immunol. 2009 Nov;2(6):495-503
19234155 - J Immunol. 2009 Mar 1;182(5):2610-9
26907215 - Annu Rev Immunol. 2016 May 20;34:335-68
10523610 - J Exp Med. 1999 Oct 18;190(8):1123-34
11104797 - J Exp Med. 2000 Dec 4;192(11):1545-52
18522803 - Gastroenterology. 2008 Aug;135(2):529-38
15841100 - Nat Rev Immunol. 2005 May;5(5):413-20
18941235 - J Immunol. 2008 Nov 1;181(9):6447-55
12154359 - Nat Immunol. 2002 Sep;3(9):822-9
26583099 - Biomed Res Int. 2015;2015:314620
9743536 - J Exp Med. 1998 Sep 21;188(6):1185-90
11104798 - J Exp Med. 2000 Dec 4;192(11):1553-62
21423809 - PLoS One. 2011 Mar 14;6(3):e17739
17325052 - Infect Immun. 2007 May;75(5):2234-43
16048541 - Immunol Rev. 2005 Aug;206:32-63
22124111 - J Exp Med. 2011 Dec 19;208(13):2705-16
22825288 - Curr Opin Infect Dis. 2012 Oct;25(5):489-99
22910541 - PLoS Pathog. 2012;8(7):e1002785
26351279 - Infect Immun. 2015 Nov;83(11):4404-15
21827802 - Adv Drug Deliv Rev. 2012 May 1;64(6):523-30
14625548 - Nat Immunol. 2003 Dec;4(12):1223-9
25902362 - Vaccine. 2015 Jun 19;33 Suppl 3:C36-41
19075245 - Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20858-63
26106395 - Front Immunol. 2015 Jun 08;6:296
12615891 - Annu Rev Immunol. 2003;21:685-711
9343353 - Annu Rev Microbiol. 1997;51:311-40
22674334 - Science. 2012 Jun 8;336(6086):1268-73
23230002 - J Exp Med. 2012 Dec 17;209(13):2367-81
24914172 - Int Immunol. 2014 Sep;26(9):517-28
17570691 - Immunity. 2007 Jun;26(6):812-26
23475182 - Nat Immunol. 2013 Apr;14(4):372-9
12427767 - Annu Rev Immunol. 2003;21:231-64
15343369 - Nat Rev Immunol. 2004 Sep;4(9):699-710
11413192 - J Exp Med. 2001 Jun 18;193(12):1373-81
24489092 - J Immunol. 2014 Mar 1;192(5):2156-66
25879814 - Curr Opin Immunol. 2015 Jun;34:130-6
23688737 - Curr Opin Immunol. 2013 Jun;25(3):366-72
References_xml
SSID ssj0000398935
Score 2.0144787
Snippet Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5...
OBJECTIVEEstablishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
Title TIR-Domain-Containing Adapter-Inducing Interferon- β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine
URI https://www.ncbi.nlm.nih.gov/pubmed/27853628
https://search.proquest.com/docview/1841138570
https://pubmed.ncbi.nlm.nih.gov/PMC5108586
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBA3iH-6ATISlUCRR34cJ7ncwqaNaUiUTupd5SQujZQmVduAtJfhHXgQnolz4iRNR5GAm6hyXDvy-XT8-fj8EPJa-Lip2BYTiVSMSy9iPncDFgTS4R53TTvCAOfLj-Lsin8Yu-Ne73vHa6lcR4fx9c64kv-RKrSBXDFK9h8k2w4KDfAb5AtPkDA8_07G50P2vpjD4Z5hlild7ME4SuQCVothVY5YOwRgLWq1LHJmDMKTwbGNvHI0PD9Fm8BQV6NXKyMch0N3YB8bI-CP2UItjVBl2apxhcRhQCHk285DG0LbBlkimvBCQHu4YgDKlu3-Aj1u5FeVlY1JGgs7b4BULLXqCjNZJqnc6Mgv6TdZlUUyPs9wqlm6LNoLozK9bm40upYMS7Q-cbXCA_bhssDXBZMO1Y62WmN7HWC6u_YBDrQMQ12aP6MvCN4Id_uCKBfzChi2B5xF1DHq28m3m1e3yG0bNBmq0ItPfmvEMx0YvSri2k6lb87xA979Nj1mnq4H3HWguemX2yE6o_vkXi1QeqTh9oD0VP6Q3LmsfTAekflO1NGbqKMd1NGfP-gbxNtb2qKNVmgz6IhqrNEKazTNKWCNtlh7TK5OT0bhGauLdrAFbJuCcTiv2oonPAHuaAbTWMVeNOUOJmlSsaqKDttCBpHFI8eMgb7HDtrUfE85UgnpPCF7eZGrZ4Sa2Fk6nskTyUUcRUD3zVgmbiITGYlpn7xq1nACShGBLXNVlKuJ5XPLcrB2Q5881Ws6WejsLZNGAn3iba122wETrm-_ydNZlXjdxVAdX-z_ccwDcncD7Odkb70s1QsgrevoZQWcX_DBkf0
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TIR-Domain-Containing+Adapter-Inducing+Interferon-+%CE%B2+%28TRIF%29+Regulates+CXCR5%2B+T+helper+Cells+in+the+Intestine&rft.jtitle=Journal+of+clinical+%26+cellular+immunology&rft.au=Kanagavelu%2C+Saravana&rft.au=Flores%2C+Claudia&rft.au=Hagiwara%2C+Shinichiro&rft.au=Ruiz%2C+Jose&rft.date=2016-10-01&rft.issn=2155-9899&rft.eissn=2155-9899&rft.volume=7&rft.issue=5&rft_id=info:doi/10.4172%2F2155-9899.1000458&rft_id=info%3Apmid%2F27853628&rft.externalDocID=27853628
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2155-9899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2155-9899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2155-9899&client=summon